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ABSTRACT 
 
Microneedles are a method of transdermal drug delivery which 
overcomes the barrier of the stratum corneum by piercing 
through with little or no pain. Microneedle have been shown to 
increase the skin permeability but the extent to which they do 
so is affected by the design of the microneedles due to certain 
parameters such as tip radius, base radius, pitch, number of 
microneedles on the patch and penetration depth. In this study 
a framework is developed to optimize these parameters and an 
optimum geometry for a microneedle shape is proposed. 
Simulations using two different softwares where then carried 
out to analyze the effect of these parameters on the diffusive 
flux and concentration of the drug in the blood. We found that 
the results of the numerical optimization and the results from 
the computer simulations led to the same conclusion about the 
optimum dimensions for the chosen geometry.  
 
INTRODUCTION 
 
Microneedles have been introduced as a means of delivering 
drug into the body transdermally in an almost painless manner. 
These micron sized needles pierce the upper layer of the skin 
(i.e. stratum corneum) which acts as the main barrier to 
transdermal delivery of drugs. The needles should extend into 
the epidermis but are not expected to touch the nerves in the 
dermis or the subcutaneous tissues. The drug diffuses across 
the rest of the epidermis by diffusion and then into the dermis 
where it is absorbed by the blood vessels (Henry et al, 1998). 
 
Microneedles can be either hollow or solid. Solid microneedles 
can either have the drugs coated on (Gill and Prausnitz, 2006) 
or the drug can be encapsulated in a polymer matrix that forms 
the needle to form dissolving microneedles (Lee et al, 2008) or 
the poke with patch approach where the needles are inserted 
and removed then followed by application of a patch on the 
surface (Martanto et al, 2004). Hollow microneedles have 
holes in them through which the drug travels to get to the 
dermis (Stoeber and Liepmann, 2005).  As far as the author 
knows the first published study on the fabrication and use 
of microneedles for transdermal drug delivery was by 
Henry et al (1998).  
 
Gill and Prausnitz (2006) developed a simple, versatile and 
controlled microneedle coating process. The microneedles 
where fabricated using the laser cutting technique and 
coated using the novel dip coating method they developed. 
They were able to uniformly coat a range of substances 
such as calcien, vitamin B and plasmid DNA unto 
microneedles using this coating method. They later in 2007 
used the same method to develop a rational basis for 
designing coating solution formulations for uniform and 
thick coatings (Gill and Prausnitz, 2007). They analysed 
the factors that affected the coating thickness, coating 
concentration and uniformity. Such factors include 
concentration of surfactant and viscosity enhancer, type of 
surfactant and viscosity enhancer and number of dips. 
McAllister et al (2003) used microneedles to deliver 
insulin to hairless rats. Microneedles where shown to 
deliver insulin at a rate good enough to have significant 
biological effect as the blood glucose concentration was 
reduced by up to 80% using microneedles.  
 
Transdermal drug delivery by microneedles in general has 
many advantages over oral delivery and delivery using 
hypodermic needles. Drugs delivered transdermally avoid 
the harsh conditions in the gastro-intestinal tract implying 
that the drug has a higher bioavailability. Also delivering 
drugs transdermally provides a controlled release rate and 
maintains a therapeutic concentration of the drug in the 
blood over long periods. This is important for drugs such 
as insulin where the patient might require a basal rate 
throughout the day (Tojo, 2005) 
 
Based on the structure of the skin (Stalheim-Smith and 
Fitch, 1993), the main concern as regards to transdermal 
delivery especially that of high molecular weight drugs 
such as insulin is the permeation across the stratum 
corneum. Microneedles pierce through this barrier and the 
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diffusion of the drug through the lower layers of the skin is 
much faster than in the stratum corneum (Henry et al, 1998). 
Also it has been shown that the drugs delivered in smaller 
quantities are more easily absorbed than the drugs delivered in 
large boluses (John and Gareth 1997). Therefore compared to 
delivering a relatively large amount at a time using 
hypodermic needles, using microneedles is expected to result 
in better absorption into the blood stream. 
 
It was suggested that the needle design has an impact on how 
well the microneedles deliver drugs (Teo et al, 2006). Most of 
the previous studies on microneedles have been focused on 
developing fabrication methods and determining performance 
of the microneedles in vitro and in vivo. Not a lot of study has 
been done on the effects of the microneedle dimensions on 
permeation through the skin. This study is concerned with the 
microneedle design and the effect of this design on 
permeability, it aims at finding an optimum geometry for 
tapered microneedles with circular base and then analysing 
how a number of geometrical parameters affect the drug 
delivery. This is done by using numerical simulations to 
optimize a developed equation that relates the permeability to 
parameters such as radius and needle length. Then using 
computer simulations, the effect of these parameters on the 
diffusive flux and blood drug concentration profile was 
analysed. 
 
Similar studies have been done by Al-Qallaf et al (2008). The 
distribution of the microneedles in a patch was optimized 
based on the top view of the microneedle when inserted in 
skin. However for effective design of these systems, one needs 
to optimise both the distribution and geometry of the 
microneedles. The focus of this paper is to optimise the 
geometry of the microneedles.  
 
METHODOLOGY 
 
Theoretical Model for Optimization 
 
Governing equation  
 
Envisage a cross section through the centre of a row of 
microneedle inserted into a portion of the skin as shown in 
figure 1. 
 
 
Figure 1. Diagram of array inserted in skin 
 
H: epidermis thickness; L: Depth to which the needle 
penetrates into skin; W: annular gap width. 
(Annular gap width at any point along the needle length) =  x 
(radius at that point)  
First the analogies on how the drug gets from the microneedle 
coating into the blood are explained. When the microneedle is 
inserted into the skin; 
 The skin fluid (mostly water) fill up the annular space 
between the needle wall and the surrounding skin 
 The drug coating on the microneedle surface dissolves 
into the surrounding fluid that occupies the annular gap 
 The dissolved drug then diffuses across the epidermis, 
past the epidermal/dermal junction, into the dermis 
where it is absorbed by the blood microcirculation. 
 The drug will dissolve into the surrounding skin fluid 
until the solubility limit is reached or until all the drug 
on the coating is diffused 
 Knowing the annular gap width and the solubility of the 
coated drug, wastage can be avoided by coating up until 
the solubility limit of the drug so that no drug remains 
on the needle. 
 So since the annular gap width is filled by fluid into 
which the drug dissolves and the total area of the 
annular gap width affects permeability this means 
geometrical parameters such as radius and needle length 
can be related to permeability. 
 
These analogies are deduced from previous studies and 
publications on skin structure (Stalheim-Smith and Fitch, 
1993), the presence of water in the epidermis (Machin et al 
1984), microneedle application method (Henry et al, 1998) 
significance of the solubility limit of the permeant 
(Hadgraft, 2004) and McAllister (2003)’s explanation of 
the annular gap width. 
 
 
                                
Figure 2. Side view of transverse section through one 
microneedle including annular gap width. 
 
Where R is the base radius of microneedle, r is the tip 
radius and Pt is the pitch or spacing between needles. 
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The pitch can be defined as 
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Putting equation (4) into the permeability equation used by 
McAllister (2003) shown in (6).  
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Then taking out the constants we have an optimization 
function given in (7). 
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The epidermis thickness can be included alongside a 
constraint; 
zHL                                          (8) 
Where z is an arbitrary value that ensures a distance between 
the needle tip and the dermis in this study z is taken as 
0.005cm and H is 0.015cm. Therefore for a given skin 
thickness, we can also find the optimum penetration length. 
And the optimization function can now be given as, 
2xH
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The other two constraints used are shown in equation (10) and 
(11); 
Rn/x               (10) 
This same constraint has been used by Al-Qallaf and Das 
(2008) in their optimization. This ensures that the needles do 
not overlap in the array.   is the aspect ratio i.e. the ratio of 
pitch to radius and is taken to be 2.7 in this case as previous 
study already shows this to be the best aspect ratio. 
Rr                (11) 
This is to ensure that the shape ranges from fully cylindrical to 
fully conical, the tip radius is never bigger than the base radius. 
The optimization function indicates the extent of permeability. 
A high value of g indicates a high permeability and a low 
value indicates a low permeability. 
 
Method of solution 
 
This equation is solved using a java optimization programme 
that has been reported by Al-Qallaf and Das (2008). The 
programme solves the problem by iterating through the whole 
sample spaces for each parameter before selecting 
combinations that gives the highest value of g. 
 
 
Figure 3. The Graphical User Interface (GIU) of 
Optimization programme 
 
Simulations of Drug Transport in Skin 
 
3D simulations in FEMLAB® (Comsol, 2005) were used to 
solve the diffusion equation in steady state mode in order 
to obtain flux values. COMSOL uses the finite element 
method to solve the partial differential equation 
(Zimmermann, 2004). A constant concentration, on the 
needle coating and a sink condition in the dermis was 
assumed. With the imposed boundary conditions, the 
software was able to solve for values of diffusive flux at 
different times till the steady state diffusive flux was 
obtained. 
 
The simulations were used to simulate a coated 
microneedle inserted in skin (figure 5) under the 
assumption that diffusion of the drug through the viable 
epidermis is the limiting process in this form of 
transdermal delivery (Davidson et al, 2008). The flux term 
is related to the permeability such that the steady state flux 
is simply a product of permeability and concentration 
(Moss et al, 2001) 
vpss CKJ                      (12) 
 
The effective skin thickness was calculated by rearranging 
the Fick’s first law equation for steady state diffusion. 
dx
dCDJss                       (13) 
Where Jss is the steady state flux of insulin across skin, D is 
the diffusion coefficient of insulin, C is the concentration 
of insulin and dC/dx is the concentration gradient. We 
define that at steady state  
dx
dC
=constant = 
eff
10
h
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   (14) 
Where C0 is insulin concentration at the coated area of 
microneedles, C1 is insulin concentration at the 
epidermal/dermal junction and heff is the skin thickness 
after microneedle has been inserted.  
 
By combing equation (13) with equation (14), we obtain 
the following equation for steady state diffusive flux Jss: 
eff
10
ss h
)CC(DJ                     (15) 
When C0 is defined to be zero (i.e., sink condition), the 
effective skin thickness is determined as follows (Davidson 
et al., 2008): 
ss
1
eff J
DCh                           (16) 
 
The results from COMSOL simulations were then linked 
to SKIN-CAD® (Biocom system, 2006) results by using 
the effective skin thickness as the distance to the 
microcirculation. So the equivalent of a drug coated unto 
the microneedle surface in COMSOL is a patch of the 
same drug placed on skin stripped of the stratum corneum, 
with a viable epidermis thickness equal to the effective 
skin thickness. 
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Simulations for Blood Concentration Profile 
 
The software SKIN-CAD® is a simulator of skin 
pharmacokinetics that was used to obtain a transient profile for 
skin penetration and blood concentration (Tojo, 2005). The 
software was used to model the application of the drug as a 
patch unto skin stripped of the stratum corneum. An 
application time of 4 hours was entered; the effective skin 
thickness and application area depended on the dimensions of 
the microneedle that was being tested. Insulin was used as the 
model drug (MW 5734 (Kutsky et al, 1973)). The feasibility of 
microneedles for delivery of insulin has been studied by Ito et 
al (2006). The properties of insulin used in this study are listed 
in table 1. The mathematical framework of SKIN-CAD® has 
been avoided in this work since it has been explained 
previously (Al-Qallaf et al., 2007). The absorption kinetics of 
insulin is quite complicated and varies from patient to patient 
and from administration to administration for the same patient. 
This variability and effect of factors such as dose size, insulin 
concentration and insulin crystals has been studied by 
Seborg et al (2008). For the purpose of this study the one-
compartment pharmacokinetics model has been defined in the 
simulation and the insulin is taken to be rapid acting insulin 
analogue. Skin binding and drug metabolism in the skin were 
neglected and 100% absorption of the drug was assumed 
(Davidson et al, 2007).   
 
The area of application in SKIN-CAD® was taken as the total 
drug area in contact with the epidermis. This is equivalent to 
the total surface area of the needle with the dissolved coating 
when it is inserted in the skin. This is illustrated in figure 4. 
 
 
Figure 4. Area of application in SKIN-CAD® is equivalent 
to the area of drug in contact with epidermis when the 
needle is inserted in the skin. 
     
SKIN-CAD® uses the finite difference method to calculate the 
diffusion through the viable epidermis. The one compartment 
pharmacokinetics model used to obtain the blood concentration 
profile is given in equation 17. 
ppEa
p
p VCKSdt
dQ
dt
dC
V                  (17) 
Vp is the volume of distribution in the blood, Cp is the 
concentration of the drug in the blood, t is time Ke is the 
elimination rate constant, dQ/dt is the rate of skin penetration, 
Sa is the area of the drug releasing surface of the delivery 
system (Tojo, 2005).  
 
Table 1. Properties of insulin 
Properties value Reference 
Diffusion coefficient (m2/s) 
Elimination rate constant (min-1) 
Volume of distribution (L) 
1.0E-06 
0.1 
12 
Lv et al, 2006 
Soeborg et al, 2008 
Soeborg et al, 2008 
 
RESULTS AND DISCUSSION 
 
The following sections present the results that were 
obtained. First of all we discuss the results of the numerical 
optimization. The effects of each parameter on the drug 
permeability are then analysed. Subsequently the 
simulations are used to determine the effect of the 
parameters on the steady state flux and the drug 
concentration in blood. 
 
 Optimum Geometry of Microneedles 
 
In this study, the optimization equation (9) along with the 
constrain equation (8, 10, 11) were implemented using java 
optimization programme. As mentioned previously, the 
highest value of the optimization function (g) which is 
directly proportional to the skin permeability has been 
determined for the input parameters as shown in Table 2. 
 
The results suggest that the highest permeability for the 
parameters chosen will be obtained for a needle of 
cylindrical shape with a radius of 0.008 cm and a 
penetration depth of 0.01 cm (assuming an epidermis 
thickness of 0.01 cm and considering constraint of 
equation 8), for an array 5 cm long containing 231 
microneedles. The maximum value of g was 147.84.  
 
Table 2. Range of values used for optimization. 
Parameter Range tested  
n 
x 
L 
R 
r  
10 – 250 
0.05 – 5 (cm) 
0.005 – 0.01 (cm) 
0.003 – 0.008 (cm) 
0.003 – 0.008 (cm) 
 
    
Figure 5. COMSOL simulation of optimum geometry 
 
It is now required to observe the relationship between each 
parameter and the optimization function, and hence the 
effect on permeability.  
 
 
Heff
Drug 
≡
Pt 
L
H
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Effect of Microneedle Base Radius     
 
For a needle 0.01cm long, cylindrical shape and array are 5cm 
long containing 231 needles, Figure 3 shows the effects of 
varying the base radius on the optimization function. The 
graph suggests that increasing the base radius will result in an 
increase in the permeability of the drug in the skin. 
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Figure 6. The effect of base radius (R) on optimization 
function (g) 
 
Effect of Microneedle Tip Radius 
 
Keeping the base radius as R=0.008cm the tip radius was 
varied so that the shape of the microneedle ranged from fully 
conical to cylindrical as shown in figure 7 the tip radius shows 
the same relationship to permeability as the base radius. 
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Figure 7. The effect tip radius (r) on the optimization 
function (g) 
 
The permeability is the highest for a cylindrical tip than a 
sharper tip. However it might be desired to make the tips 
smaller to ease insertion. Davis et al (2006) developed a 
theoretical method for predicting needle insertion force and 
fracture force for microneedles. They concluded that the 
insertion force increases with increasing interfacial area 
between the needle tip and the skin surface. All the needles 
that were tested were in the range 0.003cm to 0.008cm in 
radius. The same range was used for the radius in our 
simulations as all the micronedles fabricated in this range 
where shown to insert into skin without fracture.  
 
As expected the graph suggests that the optimization function 
will continue increasing to infinity as the size of the needle 
increases. This relationship is expected from equation 9. This 
is somewhat unrealistic, as it suggests that the biggest 
needle is better and these defeat the whole idea of “micro” 
needles. It has been said that delivering drugs in smaller 
quantity will result in better absorption (Allen et al, 2004) 
so there needs to be a biological factor so that up until a 
certain permeability will increase but beyond a certain 
value the permeability will start to decrease and the graph 
will show a different shape with a maximum point. 
 
Effect of Penetration Depth of Microneedle 
 
Due to the elastic nature of the skin and the presence of 
hair on the surface the microneedle will not penetrate its 
full length into the skin. Hence the penetration depth is 
considered instead of the total length of the microneedle. 
The values for g were plotted against changing pentration 
depth for a cylindrical needle of radius 0.008cm, for an 
array 5cm long containing 231 needles. The relationship 
between the penetration depth and the optimization 
function is shown in figure 8. As expected this indicates 
that for a given skin thickness, a longer needle will give a 
higher permeability. 
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Figure 8. The effect of penetration depth (L) on 
optimization function (g) 
      
This seems logical as the closer the needle gets to the 
dermis the lesser the distance the drug has to diffuse 
through. The constraint here is the fact that the needle has 
to be long enough to pierce the stratum corneum but short 
enough to avoid the nerves in the dermis. It is 
recommended that the needles should be longer than 
0.001cm and shorter than 0.02cm (Teo et al, 2005). 
 
Effect of Number of Microneedles 
 
For a 5cm long array, different values of the number of 
microneedles were selected and the values plotted against 
the corresponding values of the optimization function. The 
microneedle spacing is dependent on the size of the array 
and the number of microneedles in the array. This 
relationship is represented by equation 5. Figure 9 
therefore represents the relationship between the number of 
microneedles per row and the permeability, as well as the 
pitch and the permeability. The graphs shows that the more 
densely packed the needles are in the array, the higher the 
permeability of the skin. However the case may not be the 
same as what the results suggest in reality when it comes to 
the needles being inserted into the skin. If the array is too 
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densely packed it may cause difficulty on insertion. It is 
necessary to have a constraint related to the mechanical 
property of the skin which gives a limit on the spacing. 
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Figure 9. The effect of the number of microneedles per row 
in an array (n) and the optimization function (g) 
 
The results in figure 9 show that increasing the number of 
microneedles in a row of array will increase the permeability. 
This also indicates that reducing the pitch, in other words a 
denser array, will increase the permeability assuming that the 
needles are evenly spaced out. 
 
Drug Transport in Skin 
 
Having had a two dimensional mathematical framework 
relating the permeability to the geometrical parameters, the 
effects of these parameters on the flux and effective thickness 
were obtained from 3D simulations in COMSOL. Typical 
results from these simulations are shown in the figures 10 to 
13. The steady state diffusive flux increases for every 
parameter except the pitch where the steady state flux 
decreases as the pitch increases. These results correspond with 
the results from the numerical optimization as the flux and the 
permeability are related by equation (8) as mentioned earlier.  
 
A number of simulations were also carried out keeping all 
other dimensions constant except for the dimension that was 
being tested. 
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Figure 10. The effect of base radius on the effective skin 
thickness and diffusive flux 
 
 
 
 
Drug Concentration in Blood 
 
Using SKIN-CAD® the effect of the important parameters 
on the blood drug concentration profile was analysed. The 
results are shown in figure 14 to 17. Figure 14 shows that a 
more spaced out array will result in a higher concentration 
of the drug in the blood, Figure 15 shows that the deeper 
the needle penetrates into the skin, the higher the optimum 
blood concentration, Figure 16 indicates that a wider 
needle will give a higher peak blood drug concentration 
while figure 17 shows that the wider the tip, the higher the 
peak blood concentration will be. 
 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
0.00008 0.00006 0.00004 0.00002
Tip radius (m)
D
iff
us
iv
e 
Fl
ux
 (m
ol
/m
2 /s
) x
10
-6
0
0.002
0.004
0.006
0.008
0.01
0.012
Ef
fe
ct
iv
e 
Sk
in
 th
ic
kn
es
 (c
m
)
 
Figure 11. The effect of tip radius on the effective skin 
thickness and diffusive flux 
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Figure 12. The effect of the penetration depth on the 
effective skin thickness and diffusive flux 
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Figure 13. The effect of pitch on the effective skin 
thickness and the diffusive flux 
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Figure 14. Effect of the pitch (Pt) on the Insulin 
concentration in the blood 
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Figure 15. Effect of penetration depth (L) on the Insulin 
concentration in the blood 
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Figure 16. Effect of the base radius (R) on the Insulin 
concentration in the blood 
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Figure 17. Effect of tip radius (r) on  the Insulin 
concentration in the blood. 
 
Al-Qallaf and Das (2008) presented a framework for 
optimizing the dimensions of microneedles in a square 
array in order to increase drug permeability in skin. Their 
study looked at optimizing the microneedle dimensions 
which included microneedle radius, pitch, area of patch 
and number of microneedles for any given microneedle. 
The results showed that increasing the radius and number 
of microneedles will increase the optimization function, 
while increasing the area will cause a decrease in the 
optimization function. Both optimization equations related 
permeability to geometrical parameters and the results 
from the previous optimization agrees with the results 
obtained here. The framework developed in this paper is 
for optimizing the dimensions of a particular microneedle 
shape. 
 
CONCLUSION 
 
This study was aimed at relating geometrical 
parameters to the performance of solid microneedles in 
delivering drugs by developing a mathematical framework 
that relates drug permeability to these parameters. A 
microneedle shape was selected and sensitivity analysis 
was performed to analyse what effect a change in length, 
base radius, pitch, number of microneedles per row and tip 
radius would have on the permeability. Our simulations 
helped to analyse the effects of these parameters on the 
flux and concentration of the drug in blood. The vital 
findings of this work are that they give significant evidence 
that the design of the microneedle has effect on the drug 
delivery efficiency and they must be considered in the 
development of a microneedle based drug delivery system. 
Possibility of insulin delivery using solid coated 
microneedles was also considered (numerically) as the 
pharmacokinetic properties (diffusion coefficient through 
skin, volume of distribution and elimination rate constant) 
used in the simulation were those of insulin. 
Our results give the bases for follow up 
experiments or further optimization on microneedle 
designs and the distribution of the microneedles in the 
array. 
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